The impact of fibrosis and steatosis on early viral kinetics in HCV genotype 1-infected patients treated with Peg-IFN-alfa-2a and ribavirin

High-Dose Pegylated Interferon-α and Ribavirin in Nonresponder Hepatitis C Patients and Relationship With IL-28B Genotype (SYREN Trial)

(2011) Stéphane Chevaliez et al.   GASTROENTEROLOGY

Second-phase hepatitis C virus RNA decline during telaprevir-based therapy increases with drug effectiveness: Implications for treatment duration

(2011) Jeremie Guedj et al.   HEPATOLOGY

IL28B polymorphisms predict reduction of HCV RNA from the first day of therapy in chronic hepatitis C

(2011) P.-Y. Bochud et al.   JOURNAL OF HEPATOLOGY

Boceprevir for Previously Treated Chronic HCV Genotype 1 Infection

(2011) Bruce R. Bacon et al.   NEW ENGLAND JOURNAL OF MEDICINE

Telaprevir for Retreatment of HCV Infection

(2011) Stefan Zeuzem et al.   NEW ENGLAND JOURNAL OF MEDICINE

Ribavirin Improves Early Responses to Peginterferon Through Improved Interferon Signaling

(2010) Jordan J. Feld et al.   GASTROENTEROLOGY

Genetic Variation in IL28B Is Associated With Chronic Hepatitis C and Treatment Failure: A Genome-Wide Association Study

(2010) Andri Rauch et al.   GASTROENTEROLOGY

Pharmacodynamics of PEG-IFN-α-2a and HCV Response as a Function of IL28B Polymorphism in HIV/HCV-Coinfected Patients

(2010) Evaldo Stanislau Affonso de Araújo et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

Pharmacodynamics of PEG-IFN-α-2a in HIV/HCV co-infected patients: Implications for treatment outcomes

(2010) Harel Dahari et al.   JOURNAL OF HEPATOLOGY

A perspective on modelling hepatitis C virus infection

(2010) J. Guedj et al.   JOURNAL OF VIRAL HEPATITIS

Telaprevir for Previously Treated Chronic HCV Infection

(2010) John G. McHutchison et al.   NEW ENGLAND JOURNAL OF MEDICINE

Correlates and Prognostic Value of the First‐Phase Hepatitis C Virus RNA Kinetics during Treatment

(2009) Emanuele Durante‐Mangoni et al.   CLINICAL INFECTIOUS DISEASES

A Mathematical Model of Hepatitis C Virus Dynamics in Patients With High Baseline Viral Loads or Advanced Liver Disease

(2009) Harel Dahari et al.   GASTROENTEROLOGY

Peginterferon alpha-2a is associated with higher sustained virological response than peginterferon alfa-2b in chronic hepatitis C: Systematic review of randomized trials

(2009) Tahany Awad et al.   HEPATOLOGY

Insulin resistance predicts rapid virological response in non-diabetic, non-cirrhotic genotype 1 HCV patients treated with peginterferon alpha-2b plus ribavirin

(2009) Alessandro Grasso et al.   JOURNAL OF HEPATOLOGY

Early prediction of sustained virological response at day 3 of treatment with albinterferon-α-2b in patients with genotype 2/3 chronic hepatitis C

(2009) Avidan U. Neumann et al.   LIVER INTERNATIONAL

Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance

(2009) Dongliang Ge et al.   NATURE

Decreased levels of microRNA miR-122 in individuals with hepatitis C responding poorly to interferon therapy

(2009) Magdalena Sarasin-Filipowicz et al.   NATURE MEDICINE

Interferon signaling and treatment outcome in chronic hepatitis C

(2008) M. Sarasin-Filipowicz et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA